Back to search

Article

Identification and Validation of N6-methyladenosine-related Biomarkers for Bladder Cancer: Implications for Immunotherapy

2021-12-06

Abstract excerpt

<title>Abstract</title> <p>N6-methyladenosine (m6A) has emerged as one of the most important modifications of RNA. Based on the expression of 23 kinds of m<sup>6</sup>A regulatory factors, we identified three different m<sup>6</sup>A modification patterns in bladder cancer. The effects of the three kinds of m<sup>6</sup>A modification modes on clinicopathological characteristics, immune cell infiltration level, a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d0c520ec-5137-5d54-9c3c-471e2843c7cd
DOI
10.21203/rs.3.rs-1101509/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification and Validation of N6-methyladenosine-related Biomarkers for Bladder Cancer: Implications for ImmunotherapyDOI 10.21203/rs.3.rs-1101509/v1
N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder CancerSemantic proximity
RNA Modification of N6-Methyladenosine Predicts Immune Phenotypes and Therapeutic Opportunities in Kidney Renal Clear Cell CarcinomaSemantic proximity
M5C modulator mediated methylation pattern and TME cell infiltration in bladder cancerSemantic proximity
Identification of a novel RNA modifications-related model to improve bladder cancer outcomes in the framework of predictive, preventive, and personalized medicineSemantic proximity
N6-methyladenosine Methylation Related Immune Biomarkers Correlates With Clinicopathological Characteristics and Prognosis in Clear Cell Renal Cell CarcinomaSemantic proximity
An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancerSemantic proximity
Development of an m6A subtype classifier to guide precision therapy for patients with bladder cancerSemantic proximity
Expression Status and Prognostic Value of m6A RNA Methylation Regulators in Lung AdenocarcinomaSemantic proximity
Copy number variation analysis of m6 A regulators identified METTL3 as a prognostic and immune-related biomarker in bladder cancer.Semantic proximity
N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancerSemantic proximity
RNA m6A methylation regulator-mediated modification patterns and tumor microenvironment characterization in hepatocellular carcinomaSemantic proximity
m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction and its Potential Immunological Role in Uterine Corpus Endometrial CarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.